Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
600 participants
OBSERVATIONAL
2013-03-31
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microbiota and Allergy
NCT04750980
Nutrition in Children With Food Allergy
NCT01583907
Importance and Association of Gut Microbiota and Biochemical Metabolites on Children Allergic Disorder
NCT05442658
Non-Immunoglobulin E-mediated Food Allergies in Children
NCT04462978
Nutritional Status in Children With Food Allergy: Evaluation of a New Supplement
NCT06751810
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cow milk allergy children
Children affected by Immunoglobulin E medited cow milk allergy
No interventions assigned to this group
healthy control
healthy infants
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 6-12 months
Exclusion Criteria
* congenital cardiac defects
* active tuberculosis
* autoimmune diseases
* immunodeficiency
* chronic inflammatory bowel diseases
* celiac disease, cystic fibrosis
* metabolic diseases
* malignancy
* chronic pulmonary diseases
* malformations of the gastrointestinal tract
* suspected eosinophilic esophagitis or eosinophilic enterocolitis
* suspected food-protein-induced enterocolitis syndrome.
6 Months
12 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federico II University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roberto Berni Canani
MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Naples Federico II
Naples, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Roberto Berni Canani
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02/14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.